Atlas Trials

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK1278863A in Healthy Subjects

Clinical trial NCT00750256 · COMPLETED

Trial details

NCT number
NCT00750256
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Anaemia
Start date
2008-07-07
Primary completion
2008-12-12
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.